Endothelial dysfunction impairs vascular neurotransmission in tail arteries

Neurochemistry International

Volumn 80, Issue , 2015, Pages 7-13

  Sousa, Joana B ^a,b   Fresco, Paula ^a,b   Diniz, Carmen ^a,b  

^a UNIVERSITY OF PORTO   (Portugal)

^b Center for Drug Discovery and Innovative Medicines   (Portugal)

Author keywords

Adenosine; Endothelium dysfunction; Nitric oxide; Noradrenaline; SHR

Indexed keywords

8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE KINASE INHIBITOR; ALLOPURINOL; APOCYNIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDOMETACIN; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE; NITROBENZYLTHIOINOSINE; NORADRENALIN; NUCLEOSIDE TRANSPORTER; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN SYNTHASE INHIBITOR; PYRIMIDINE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TRITIUM; XANTHINE OXIDASE INHIBITOR; ADENOSINE;

ADRENERGIC TRANSMISSION; ADULT; ANIMAL TISSUE; ARTICLE; BIOAVAILABILITY; BLOOD PRESSURE; BLOOD VESSEL TONE; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVITY; EVALUATION STUDY; EVOKED RESPONSE; HYPERTENSION; MALE; NONHUMAN; NORADRENALIN RELEASE; OXIDATIVE STRESS; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; SYMPATHETIC NERVE; TAIL ARTERY; ANIMAL; ARTERY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SYNAPTIC TRANSMISSION; TAIL; VASCULAR ENDOTHELIUM; VASCULARIZATION; WISTAR KYOTO RAT;

HUMAN ECHOVIRUS 1;

ADENOSINE; ANIMALS; ARTERIES; ENDOTHELIUM, VASCULAR; MALE; NOREPINEPHRINE; RATS; RATS, INBRED SHR; RATS, INBRED WKY; REACTIVE OXYGEN SPECIES; SYNAPTIC TRANSMISSION; TAIL;

EID: 84919372516     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2014.11.001     Document Type: Article

References (50)

1. Ahmad A., Schaack J.B., White C.W., and Ahmad S. Adenosine a2a receptor-dependent proliferation of pulmonary endothelial cells is mediated through calcium mobilization, pi3-kinase and erk1/2 pathways Biochem. Biophys. Res. Commun 434 2013 566 571
2. Balligand J.L., Kelly R.A., Marsden P.A., Smith T.W., and Michel T. Control of cardiac muscle cell function by an endogenous nitric oxide signaling system Proc. Natl. Acad. Sci. U.S.A. 90 1993 347 351
3. Bernatova I., Conde M.V., Kopincova J., Gonzalez M.C., Puzserova A., and Arribas S.M. Endothelial dysfunction in spontaneously hypertensive rats: focus on methodological aspects J. Hypertens. Suppl 27 2009 S27 S31
4. Blanco-Rivero J., Sastre E., Caracuel L., Granado M., and Balfagon G. Breast feeding increases vasoconstriction induced by electrical field stimulation in rat mesenteric artery. Role of neuronal nitric oxide and ATP PLoS ONE 8 2013 e53802
5. Bobalova J., and Mutafova-Yambolieva V.N. Co-release of endogenous ATP and noradrenaline from guinea-pig mesenteric veins exceeds co-release from mesenteric arteries Clin. Exp. Pharmacol. Physiol 28 2001 397 401
6. Bobalova J., Bobal P., and Mutafova-Yambolieva V.N. High-performance liquid chromatographic technique for detection of a fluorescent analogue of ADP-ribose in isolated blood vessel preparations Anal. Biochem 305 2002 269 276
7. Brandes R.P., and Kreuzer J. Vascular NADPH oxidases: molecular mechanisms of activation Cardiovasc. Res 65 2005 16 27
8. Bucher B., Ouedraogo S., Tschopl M., Paya D., and Stoclet J.C. Role of the L-arginine-NO pathway and of cyclic GMP in electrical field-induced noradrenaline release and vasoconstriction in the rat tail artery Br. J. Pharmacol 107 1992 976 982
9. Cederqvist B., and Gustafsson L.E. Modulation of neuroeffector transmission in guinea-pig pulmonary artery and vas deferens by exogenous nitric oxide Acta Physiol. Scand 150 1994 75 81
10. Conti V., Russomanno G., Corbi G., Izzo V., Vecchione C., and Filippelli A. Adrenoreceptors and nitric oxide in the cardiovascular system Front. Physiol 4 2013 321
11. Datla S.R., and Griendling K.K. Reactive oxygen species, NADPH oxidases, and hypertension Hypertension 56 2010 325 330
12. Demel S.L., and Galligan J.J. Impaired purinergic neurotransmission to mesenteric arteries in deoxycorticosterone acetate-salt hypertensive rats Hypertension 52 2008 322 329
13. Diniz C., Fresco P., Leal S., and Gonçalves J. Adenosine receptors involved in modulation of noradrenaline release in isolated rat tail artery Eur. J. Pharmacol 504 2004 17 25
14. Diniz C., Fresco P., and Goncalves J. Regional differences in extracellular purine degradation in the prostatic and epididymal portions of the rat vas deferens Clin. Exp. Pharmacol. Physiol 32 2005 721 727
15. Droge W. Free radicals in the physiological control of cell function Physiol. Rev 82 2002 47 95
16. Dunwiddie T.V., and Masino S.A. The role and regulation of adenosine in the central nervous system Annu. Rev. Neurosci 24 2001 31 55
17. Fresco P., Diniz C., Queiroz G., and Gonçalves J. Release inhibitory receptors activation favours the a2a-adenosine receptor-mediated facilitation of noradrenaline release in isolated rat tail artery Br. J. Pharmacol 136 2002 230 236
18. Fresco P., Diniz C., and Goncalves J. Facilitation of noradrenaline release by activation of adenosine a(2a) receptors triggers both phospholipase c and adenylate cyclase pathways in rat tail artery Cardiovasc. Res 63 2004 739 746
19. Furchgott R.F., and Zawadzki J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine Nature 288 1980 373 376
20. Guimaraes S., and Moura D. Vascular adrenoceptors: an update Pharmacol. Rev 53 2001 319 356
21. Guzman-Gutierrez E., Westermeier F., Salomon C., Gonzalez M., Pardo F., and Leiva A. Insulin-increased l-arginine transport requires a(2a) adenosine receptors activation in human umbilical vein endothelium PLoS ONE 7 2012 e41705
22. Harrison R. Structure and function of xanthine oxidoreductase: where are we now? Free Radic. Biol. Med 33 2002 774 797
23. Hsieh H.J., Liu C.A., Huang B., Tseng A.H., and Wang D.L. Shear-induced endothelial mechanotransduction: the interplay between reactive oxygen species (ROS) and nitric oxide (NO) and the pathophysiological implications J. Biomed. Sci 21 2014 3
24. Kasparov S., and Teschemacher A.G. Altered central catecholaminergic transmission and cardiovascular disease Exp. Physiol 93 2008 725 740
25. Latini S., and Pedata F. Adenosine in the central nervous system: release mechanisms and extracellular concentrations J. Neurochem 79 2001 463 484
26. Levitt B., Head R.J., and Westfall D.P. High-pressure liquid chromatographic-fluorometric detection of adenosine and adenine nucleotides: application to endogenous content and electrically induced release of adenyl purines in guinea pig vas deferens Anal. Biochem 137 1984 93 100
27. Moncada S., Palmer R.M., and Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology Pharmacol. Rev 43 1991 109 142
28. Moncada S., Rees D.D., Schulz R., and Palmer R.M. Development and mechanism of a specific supersensitivity to nitrovasodilators after inhibition of vascular nitric oxide synthesis in vivo Proc. Natl. Acad. Sci. U.S.A. 88 1991 2166 2170
29. Okamura T., Ayajiki K., Fujioka H., Toda M., Fujimiya M., and Toda N. Effects of endothelial impairment by saponin on the responses to vasodilators and nitrergic nerve stimulation in isolated canine corpus cavernosum Br. J. Pharmacol 127 1999 802 808
30. Pacher P., Beckman J.S., and Liaudet L. Nitric oxide and peroxynitrite in health and disease Physiol. Rev 87 2007 315 424
31. Paravicini T.M., and Touyz R.M. NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities Diabetes Care 31 Suppl. 2 2008 S170 S180
32. Puzserova A., Kopincova J., and Bernatova I. [Endothelial (dys)function in the experimental model of primary hypertension] Cesk. Fysiol 59 2010 4 14
33. Ray C.J., and Marshall J.M. The cellular mechanisms by which adenosine evokes release of nitric oxide from rat aortic endothelium J. Physiol 570 2006 85 96
34. Reid J.J., Vo P.A., Lieu A.T., Wong-Dusting H.K., and Rand M.J. Modulation of norepinephrine-induced vasoconstriction by endothelin-1 and nitric oxide in rat tail artery J. Cardiovasc. Pharmacol 17 Suppl. 7 1991 S272 S275
35. Rocha A., Sousa J.B., and Diniz C. Adenosinergic system in the mesenteric vessels Gaze D.C. The Cardiovascular System - Physiology, Diagnostics and Clinical Implications 2012 Intech Rijeka 109 134
36. Rocha-Pereira C., Arribas S.M., Fresco P., Gonzalez M.C., Goncalves J., and Diniz C. Impaired inhibitory function of presynaptic a1-adenosine receptors in SHR mesenteric arteries J. Pharmacol. Sci 122 2013 59 70
37. Rocha-Pereira C., Sousa J.B., Vieira-Rocha M.S., Fresco P., Goncalves J., and Diniz C. Differential inhibition of noradrenaline release mediated by inhibitory a(1)-adenosine receptors in the mesenteric vein and artery from normotensive and hypertensive rats Neurochem. Int 62 2013 399 405
38. Sawynok J., and Liu X.J. Adenosine in the spinal cord and periphery: release and regulation of pain Prog. Neurobiol 69 2003 313 340
39. Schramm A., Matusik P., Osmenda G., and Guzik T.J. Targeting NADPH oxidases in vascular pharmacology Vascul. Pharmacol 56 2012 216 231
40. Schwieler J.H., and Hjemdahl P. Influence of angiotensin-converting enzyme inhibition on sympathetic neurotransmission: possible roles of bradykinin and prostaglandins J. Cardiovasc. Pharmacol 20 Suppl. 9 1992 S39 S46
41. Stankevicius E., Kevelaitis E., Vainorius E., and Simonsen U. [Role of nitric oxide and other endothelium-derived factors] Medicina 39 2003 333 341
42. Stegbauer J., Kuczka Y., Vonend O., Quack I., Sellin L., and Patzak A. Endothelial nitric oxide synthase is predominantly involved in angiotensin II modulation of renal vascular resistance and norepinephrine release Am. J. Physiol. Regul. Integr. Comp. Physiol 294 2008 R421 R428
43. Torok J. Participation of nitric oxide in different models of experimental hypertension Physiol. Res 57 2008 813 825
44. Vanhoutte P.M. Endothelial dysfunction: the first step toward coronary arteriosclerosis Circ. J. 73 2009 595 601
45. Vanhoutte P.M., and Mombouli J.V. Vascular endothelium: vasoactive mediators Prog. Cardiovasc. Dis 39 1996 229 238
46. Vanhoutte P.M., Shimokawa H., Tang E.H., and Feletou M. Endothelial dysfunction and vascular disease Acta Physiol 196 2009 193 222
47. Vaz-da-Silva M.J., Guimaraes S., and Moura D. Adenosine and the endothelium-dependent modulation of 3h-noradrenaline release in the canine pulmonary artery Naunyn Schmiedebergs Arch. Pharmacol 352 1995 640 645
48. Voloshyna I., Carsons S., Littlefield M.J., Rieger J.M., Figler R., and Reiss A.B. Adenosine a(2a) receptor activation supports an atheroprotective cholesterol balance in human macrophages and endothelial cells Biochim. Biophys. Acta 1831 2013 407 416
49. Westcott E.B., and Segal S.S. Perivascular innervation: a multiplicity of roles in vasomotor control and myoendothelial signaling Microcirculation 20 2013 217 238
50. Wiklund N.P., Wiklund C.U., Cederqvist B., Ohlen A., Hedqvist P., and Gustafsson L.E. Endothelin modulation of neuroeffector transmission in smooth muscle J. Cardiovasc. Pharmacol 17 Suppl. 7 1991 S335 S339